C366-0021 Screening compound: N-{4-[5-(4-methoxyphenyl)-1-(4-methylbenzenesulfonyl)-4,5-dihydro-1H-pyrazol-3-yl]phenyl}methanesulfonamide

C366-0021 Screening compound: N-{4-[5-(4-methoxyphenyl)-1-(4-methylbenzenesulfonyl)-4,5-dihydro-1H-pyrazol-3-yl]phenyl}methanesulfonamide
C366-0021 Screening compound: N-{4-[5-(4-methoxyphenyl)-1-(4-methylbenzenesulfonyl)-4,5-dihydro-1H-pyrazol-3-yl]phenyl}methanesulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C366-0021
N-{4-[5-(4-methoxyphenyl)-1-(4-methylbenzenesulfonyl)-4,5-dihydro-1H-pyrazol-3-yl]phenyl}methanesulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C366-0021

Molecular Formula

C24H25N3O5S2 (C24 H25 N3 O5 S2)

Compound Name

N-{4-[5-(4-methoxyphenyl)-1-(4-methylbenzenesulfonyl)-4,5-dihydro-1H-pyrazol-3-yl]phenyl}methanesulfonamide

IUPAC name

N-{4-[5-(4-methoxyphenyl)-1-(4-methylbenzenesulfonyl)-45-dihydro-1H-pyrazol-3-yl]phenyl}methanesulfonamide

SMILES

Cc(cc1)ccc1S(N(C(C1)c(cc2)ccc2OC)N=C1c(cc1)ccc1NS(C)(=O)=O)(=O)=O

InChI

InChI=1S/C24H25N3O5S2/c1-17-4-14-22(15-5-17)34(30,31)27-24(19-8-12-21(32-2)13-9-19)16-23(25-27)18-6-10-20(11-7-18)26-33(3,28)29/h4-15,24,26H,16H2,1-3H3/t24-/m0/s1

InChI Key

IQDIIPRBBMMPSV-DEOSSOPVSA-N

MDL Number (MFCD)

MFCD04463804

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

499.61

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.283

Distribution Coefficient, logD

4.237

Water Solubility, LogSw

-4.22

Polar Surface Area

91.763

Acid Dissociation Constant (pKa)

8.36

Base Dissociation Constant (pKb)

-1.28

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

20.80

C366-0021 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Targeted Diversity Library (40567 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with C366-0021 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C366-0021?
Check Price and Availability of C366-0021, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C366-0021 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C366-0021
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C366-0021
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C366-0021 available by request